TrialClinical lung cancer2017

Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer.

Tianhong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.